
India’s CRDMO industry is poised for significant growth, with its market size expected to double from US$ 7 billion to US$ 14 billion by 2028, driven by a 14% CAGR, reveals a report by Macquarie Equity Research. Increasing pharmaceutical outsourcing, regulatory support, and global supply chain shifts favor India’s position...









